CDG UK
To preserve and protect good health for the public benefit by supporting those affected by Congenital Disorders of Glycosylation and funding research into Congenital Disorders of Glycosylation and disseminating all useful results into the public domain.
Financial health, per its FY2025 accounts
The accounts state that the charity held unrestricted reserves of £96,697 at the end of the period, having incurred a planned deficit due to a significant grant awarded to the University of Utah. The trustees report that these reserves are held for future projects such as family grants, research, and events.
What the accounts disclose
Trustees
- Julia Boonnakchair
- Chantelle Dixon
- Nicole Rourke
- Teerasak Boonnak
- Tim Jardine
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/07/2025 | £30k | £60k |
| 31/07/2024 | £110k | £15k |
| 31/07/2023 | £7k | £11k |
| 31/07/2022 | £19k | £5k |
| 31/07/2021 | £4k | £2k |
Common questions
Is CDG UK financially healthy?
Per its FY2025 accounts: The accounts state that the charity held unrestricted reserves of £96,697 at the end of the period, having incurred a planned deficit due to a significant grant awarded to the University of Utah. The trustees report that these reserves are held for future projects such as family grants, research, and events. Its FY2025 accounts were independently examined.